What Is Sarepta Therapeutics, Inc. (SRPT) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Sarepta Therapeutics, Inc.'s intrinsic value is estimated at $30.65, suggesting a +70.7% average upside from the current price of $17.96. While 8 models see room for appreciation, model agreement is not unanimous as 5 models flag potential overvaluation. Model dispersion is worth noting: First Chicago targets $98.80 (+450.1%), versus Bayesian DCF at $0.88 (-95.1%). This +545.2% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About SRPT?
13 of 13 models are currently active for SRPT. Of these, 8 models suggest upside while 5 models suggest overvaluation. The Bayesian DCF estimates SRPT's intrinsic value at $0.88, implying -95.1% downside from the current price. See which stocks rank higher →
How Does SRPT Rank in Pharmaceutical Preparations?
Among 469 Pharmaceutical Preparations stocks, SRPT ranks #42 by Quality of Company score. CirclFi's QOC score of 7.8/10 evaluates 32 fundamental signals. A score of 7.8 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a biopharma enterprise, Sarepta Therapeutics, Inc. operates in a sector where revenue per drug is a critical driver of valuation. Investors evaluating SRPT should weigh these sector-specific dynamics alongside our model-derived fair values.
Is SRPT a Value Trap?
CirclFi's Value Trap algorithm assigns SRPT a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Sarepta Therapeutics, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Sarepta Therapeutics, Inc.'s fundamental quality profile registers 7.8/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +545.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every SRPT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across SRPT's 13 active models, average confidence is 35%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad